ARTICLE | Company News
Shire receives Adderall XR approval
October 12, 2001 7:00 AM UTC
Shire (LSE:SHP; SHPGY) received FDA marketing approval for its Adderall XR once-daily treatment for attention deficit hyperactivity disorder (ADHD). The product uses SHP's Microtrol bead delayed-relea...